Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccines01:21

Vaccines

25
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
25
Vaccinations01:51

Vaccinations

53.4K
Overview
53.4K
Vaccine Production01:23

Vaccine Production

27
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
27
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

104
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
104
Subviral Agents01:29

Subviral Agents

724
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
724
Cancer Vaccines01:30

Cancer Vaccines

1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lipopeptide adjuvants for antibiotics and vaccines: the future step in the fight against multidrug-resistant and extensively drug-resistant pathogens.

Exploration of drug science·2025
Same author

Synthesis and evaluation of Trehalose-Pks13 inhibitor conjugates targeting mycobacteria.

Carbohydrate research·2025
Same author

Discovery of 2,4,5-Substituted Benzoxazole Derivatives as Pks13 Inhibitors via the Scaffold Hopping Strategy.

ACS infectious diseases·2025
Same author

Synthesis of the Pentasaccharide Unit of the <i>Pseudomonas aeruginosa</i> Exopolysaccharide Psl Conjugation with CRM197, and Evaluation of Antigenicity in a QS-21/Pam<sub>3</sub>CSK<sub>4</sub>-Liposomal Formulation.

Molecules (Basel, Switzerland)·2025
Same author

Recombinant-Chemosynthetic Biosensors for Probing Cell Surface Signaling of Red Blood Cells and Other Cells.

Chemical & biomedical imaging·2025
Same author

Synthesis and Evaluation of a Self-Adjuvanting Pseudomonal Vaccine Based on Major Outer Membrane Porin OprF Epitopes Formulated with Low-Toxicity QS-21-Containing Liposomes.

Bioconjugate chemistry·2023

Related Experiment Video

Updated: Mar 22, 2026

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.8K

Recent Advances in Subunit Vaccine Carriers.

Abhishek Vartak1, Steven J Sucheck2

  • 1Department of Chemistry and Biochemistry, The University of Toledo, 2801 West Bancroft Street, Toledo, OH 43606, USA. Abhishek.Vartak@rockets.utoledo.edu.

Vaccines
|April 23, 2016
PubMed
Summary

Synthetic subunit vaccines face challenges with low immunogenicity. Novel nano-particulate vaccine carriers are being developed to improve antigen presentation and immune responses for cancer and infectious disease immunotherapy.

Keywords:
liposomesnanoparticlespolymeric nanoparticlesvaccines

More Related Videos

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

5.5K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

8.1K

Related Experiment Videos

Last Updated: Mar 22, 2026

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.8K
Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

5.5K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

8.1K

Area of Science:

  • Vaccinology
  • Nanotechnology
  • Immunology

Background:

  • Synthetic subunit vaccines offer safety advantages over live attenuated vaccines but often exhibit lower immunogenicity.
  • Developing effective vaccine carriers is crucial for enhancing the immune response to subunit antigens.
  • Physio-chemical properties of carriers can be optimized for antigen presentation and immune cell targeting.

Purpose of the Study:

  • To review recent advancements in the design of nano-particulate vaccine carriers.
  • To highlight strategies for improving antigen presentation, cellular trafficking, and immune responses.
  • To discuss the application of these carriers in active immunotherapy for cancer and infectious diseases.

Main Methods:

  • Modification of carrier physio-chemical properties for optimal antigen presentation and endosomal escape.
  • Incorporation of antigens and ligands for targeted delivery to dendritic cells.
  • Covalent attachment or entrapment of adjuvants to enhance cellular and humoral immunity.
  • Utilizing advancements in technology, analytical methods, and computational approaches.

Main Results:

  • Multi-functional nano-particulate systems demonstrate potential for enhanced vaccine efficacy.
  • Tailored carrier properties improve bio-distribution and cellular trafficking of antigens.
  • Targeted delivery and adjuvant incorporation boost cellular and humoral immune responses.
  • Liposomes, polymeric nanoparticles, and inorganic nanoparticles are key carrier types.

Conclusions:

  • Nano-particulate vaccine carriers represent a promising strategy to overcome the immunogenicity limitations of subunit vaccines.
  • Optimized carrier design facilitates potent immune responses for active immunotherapy.
  • Continued technological and methodological advancements are driving innovation in vaccine carrier development.